Glipizide Tablet, Extended Release
Product Images NDC 70518-3645

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 70518-3645). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Glipizide 2.5 mg extended-release oral tablets, containing 30 tablets, repackaged by RemedyRepack Inc. The label includes NDC 70518-3645-00, manufacturer Northstar Rx LLC, Memphis, TN, and storage instructions. Warning to keep medication out of children's reach is visible.*
FDA Label Image

Glipezide Usp (C65265e1 A7eb 43ea 890a 00a227570956 01)

Glipezide Usp (C65265e1 A7eb 43ea 890a 00a227570956 01)
Chemical structure diagram of Glipizide, illustrating the molecular configuration with labeled rings and functional groups as shown in the product data for Glipizide extended-release tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.